Together, these data show that LGRFYAASG-pen impairs tumor cell adhesion and migration, likely by inhibiting annexin A2-dependent membrane-cytoskeleton attachment and organization of actin-based structures. This evidence concerns the gene ANXA2 and neoplasm.